Home > Insider Trading > Filing (0001209191-19-044310)

Filing Details

Accession Number:: 0001209191-19-044310
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2019-08-02 17:22:13
Reporting Period:: 2019-07-01

Accepted Time:: 2019-08-02 17:22:13
Original Submission Date:: 2019-07-02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597313	Viewray Inc.	VRAY	Electromedical & Electrotherapeutic Apparatus (3845)	421777485

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1637089	F. James Dempsey	C/O Viewray, Inc. 2 Thermo Fisher Way Oakwood Village OH 44146	Chief Scientific Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-07-01	5,146	$0.68	226,119	No	4	M	Direct
Common Stock	Disposition	2019-07-01	5,146	$8.63	220,973	No	4	S	Direct
Common Stock	Acquisiton	2019-07-01	16,469	$0.68	237,442	No	4	M	Direct
Common Stock	Disposition	2019-07-01	16,469	$8.64	220,973	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-07-01	5,146	$0.00	61,752	$0.68
Common Stock	Stock Option (right to buy)	Disposition	2019-07-01	16,469	$0.00	197,635	$0.68

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
56,606		2020-06-29	No	4	M	Direct
181,166		2020-06-29	No	4	M	Direct

Footnotes

Transaction was not included in previous filing.
The transactions reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.46 to $8.80 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Previous filing listed total as 317,498 shares. Accurate total is 220,973 shares, of which 38,371 shares represents shares granted as Restricted Stock Units. As of the transaction date, none of the restricted stock units have vested.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.46 to $8.84 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 38,371 shares granted as Restricted Stock Units. As of the transaction date, none of the restricted stock units have vested.
The shares subject to the option vested in 36 monthly installments beginning June 17, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 36 month anniversary of the Vesting Commencement Date.
The shares subject to the option vested in 48 monthly installments beginning July 14, 2010 (the "Vesting Commencement Date") and became exercisable on each monthly anniversary thereafter, such that 100% of the shares subject to the option were fully vested on the 48 month anniversary of the Vesting Commencement Date.